Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
A Committee Member Biographies Michael T. Clegg (NAS), (Chair), is the Donald Bren Professor of Bio- logical Sciences at the University of California, Irvine, and foreign secre- tary of the National Academy of Sciences. He also serves as the chair of the National Academy of Sciences Council Committee on International Affairs. His research specialty is population genetics and molecular evo- lution, particularly the study of evolutionary genetic changes in plant populations. Prior to moving to Irvine, he was professor of genetics at the University of California, Riverside. He served as dean of the College of Natural and Agricultural Sciences, University of California, Riverside from 1994 to 2000, and he was the founding director of the Genomics Institute, now renamed the UCR Institute for Integrative Genome Biology. He received his B.S. in agricultural genetics and Ph.D. in genetics at the University of California, Davis. Dr. Clegg has received numerous awards including a Guggenheim Fellowship (1981) and the Darwin Prize of Edin- burgh University (1995). Dr. Clegg was elected to membership in the U.S. National Academy of Sciences in 1990, and he was elected a fellow of the American Academy of Arts and Sciences in 1992. He served as president of the American Genetic Association (1987), president of the International Society for Molecular Biology & Evolution (2002), and chair of the Section on Agriculture, Food and Natural Resources of the American Association for the Advancement of Science (2003). Gail H. Cassell (IOM) is Vice President for Scientific Affairs and Distin- guished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Com- 77
78 APPENDIX A pany in Indianapolis, Indiana. She is the former Charles H. Â McCauley Professor and chairman of the Department of Microbiology at the Uni- versity of Alabama School of Medicine and Dentistry at Birmingham. Dr. Cassell was a member of the National Institutes of Health (NIH) Directorâs Advisory Committee and a member of the Advisory Council of the National Institute of Allergy and Infectious Diseases of NIH. She was named to the original Board of Scientific Councilors of the Center for Infectious Diseases, Centers for Disease Control and served as chair of the Board. She recently served a three-year term on the Advisory Board of the Director of the Centers for Disease Control and is a member of the Secretary of Health and Human Services Advisory Council of Public Health Preparedness. Currently she is a member of the Science Board of the Federal Food and Drug Administration. Since 1996, she has been a member of the U.S.-Japan Cooperative Medical Science Program respon- sible for advising the respective governments (U.S. State Department/ Japan Ministry of Foreign Affairs) on joint research agendas. She has served on several Âeditorial boards of scientific journals and has authored over 250 articles and book chapters. Dr. Cassell has received national and international awards and an honorary degree for her research in infec- tious diseases. She is a member of the Institute of Medicine (IOM) of the National Academies and is currently serving on the IOM Council. She is a past president of the American Society for Microbiology (ASM) and has served as chair of the ASM Public and Scientific Affairs Board, is a former vice-president of the International Union of Microbiological Societies, has served as an advisor to the White House Office of Science and Technology Policy, and has been an invited participant in numerous congressional hearings and briefings related to infectious diseases, antimicrobial resis- tance, and biomedical research. She has served two terms on the Liaison Committee on Medical Education, the accrediting body for U.S. medical schools as well as other national committees involved in establishing poli- cies for training in the biomedical sciences. She is currently a member of the Executive Committee of the Board of Visitors of Columbia University School of Medicine, the Board of Directors of the Burroughs Wellcome Fund, the Advisory Council of the School of Nursing of Johns Hopkins University, and an Emeritus Director of Research!America. Hernan Chaimovich is professor in the Department of Biochemistry of the Institute of Chemistry, Universidade de SÃ£o Paulo (USP), Brazil. He received a degree in Biochemistry from the Universidad de Chile, worked with Osvaldo Cori in apyrase enzymology, and spent two and a half years in the United States working under the supervision of C.A. Bunton (University of California, Santa Barbara) and F.H. Westheimer (Harvard University) in physical organic chemistry. He returned to Chile as an
APPENDIX A 79 assistant professor of Biochemistry and moved to Brazil in 1969, first as a fellow of the FundaÃ§Ã£o de Amparo Ã Pesquisa do Estado de SÃ£o Paulo in the Department of Physiology at the Faculty of Medicine, Universidade de SÃ£o Paulo (USP) and later in the Department of Biochemistry of the Institute of Chemistry, USP, where he became a full professor in 1985. Dr. Chaimovichâs research is in interfacial effects on chemical and biologi- cal reactivity using micelles and vesicles as models. The contributions of his group, including theoretical and experimental studies of the effect of micelles and vesicles on a number of chemical reactions, have contrib- uted to dissecting the effect of these aggregates on chemical reactivity. Dr. Chaimovich participated in the establishment of an interdisciplin- ary graduate course in Biotechnology and an undergraduate Course in Molecular Sciences, which he coordinated for four years. He was a direc- tor of the Teachers Association of USP. An active member of the Brazilian Society of Biochemistry and Molecular Biology, he was elected president of the Society in 1994. In recognition of his academic contributions, he was elected a fellow of the American Association for the Advancement of Science and a member of the Ordem Nacional do MÃ©rito CientÃfico e TecnolÃ³gico. Dr. Chaimovich has recently served as vice-president for external relations for the International Council for Science (ICSU). Roderick Flower, FRS, is professor of Biochemical Pharmacology at the William Harvey Research Institute, Queen Mary, University of London. Dr. Flower received his postgraduate training at the department of phar- macology in the Royal College of Surgeons of England under the super- vision of Sir John Vane and subsequently worked as part of the prosta- glandin research team at the Wellcome Foundation in Kent until 1984. Dr. Flower served as Chair of Pharmacology at the University of Bath, where he also served as head of the School of Pharmacy and Pharmacology (1987-1989). In 1989, he moved to the medical college of St. Bartholomewâs Hospital, where he became a director and founding member of the Wil- liam Harvey Research Institute, and started a new Department of Bio- chemical Pharmacology. He served as head of the Institute (1998-2002) and was also Wellcome Principal Research fellow (1994-2007). His main interests are the mechanism of action of anti-inflammatory drugs includ- ing Cox inhibitors and glucocorticoid steroids. Dr. Flower has published over 200 peer-reviewed research papers and holds several patents. He has trained numerous Ph.D. students, hosted many researchers from overseas in his group and made important contributions to undergraduate teach- ing. He has served on editorial and scientific boards and was president of the British Pharmacological Society (2000-2003). Dr. Flowerâs honors include the Thomas Woodcock Physiology Prize (University of Sheffield 1972), the British Pharmacological Societyâs Sandoz Prize (1978), the Gad-
80 APPENDIX A dum Memorial Lecture and Medal of The British Pharmacological Society (1986), Fellow of the Academy of Medical Sciences (1999), Fellow of Aca- demia Europeae (2001), the William Withering Medal of the Royal College of Physicians (2003), the Lifetime Achievement Award of the International Society of Inflammation Associations (2005), and the Bayliss-Starling Prize Lecture of the Physiological Society (2006). He was elected a fellow of the Royal Society in 2003 and served on the international organizing commit- tee for a workshop hosted by the Royal Society, the InterAcademy Panel on International Issues, and ICSU in 2006 on implications of life sciences developments for the Biological and Toxin Weapons Convention. David Franz is chief biological scientist at the Midwest Research Institute. He served in the U.S. Army Medical Research and Materiel Command for 23 of his 27 years on active duty. Dr. Franz has served as both deputy com- mander and then commander of the U.S. Army Medical Research Institute of Infectious Diseases and as deputy commander of the U.S. Army Medi- cal Research and Materiel Command. Prior to joining the Command, he served as group veterinarian for the 10th Special Forces Group (Airborne). Dr. Franz served as chief inspector on three United Nations Special Com- mission biological warfare inspection missions to Iraq, and as technical advisor on long-term monitoring. He also served as a member of the first two United States/United Kingdom teams that visited Russia in support of the Trilateral Joint Statement on Biological Weapons, and as a member of the Trilateral Experts Committee for biological weapons negotiations. Dr. Franz has served on numerous National Research Council (NRC) committees working on biosecurity-related issues in the United States and internationally, and was a member of the committee that produced the NRC report Biotechnology Research in an Age of Terrorism (2004). He is cur- rently a member of the National Science Advisory Board for Biosecurity and is co-chair of its international collaborations working group. Andrzej GÃ³rski is professor of medicine and immunology at the Medical University of Warsaw and vice president of the Polish Academy of Sci- ences. He is board certified in internal medicine with a subspecialty cer- tification in clinical immunology. Dr. GÃ³rski received his M.D. (1970) and Ph.D. (1973) degrees from the Medical University of Warsaw and was a Fulbright Scholar at the Sloan-Kettering Institute for Cancer Research. He has been a visiting professor at Adelaide Childrenâs Hospital, Australia, the Weizmann Institute of Science, Israel, the University of London United Medical and Dental Schools of Guyâs and St. Thomasâs Hospitals, Eng- land, and the Universidad Autonoma, Madrid, Spain. Dr. GÃ³rski served as prorector for Scientific Affairs & International Cooperation (1993-1996) and as rector (1996-1999) of The Medical University of Warsaw. From
APPENDIX A 81 1999-2007 he was also director of the L. Hirszfeld Institute of Immunology and Experimental Therapy at the Polish Academy of Sciences. Dr. GÃ³rski has authored over 100 scientific publications, serves as the editor in chief of Archivum Immunologiae et Therapiae Experimentalis, and has served as a member of the editorial board of Science & Engineering Ethics. His awards include the Meller Award for excellence in cancer research from the Sloan- Kettering Institute, the ICRETT award and the Yamagiwa-Yoshida award from the International Union Against Cancer, the J. Sniadecki Memorial award from the Polish Academy of Sciences (the highest award in medi- cal sciences in Poland), and the Gloria Medicinae, awarded by The Polish Medical Association. In addition, Dr. GÃ³rski is a member of the Commit- tee for Ethics in Science at the Polish Academy of Sciences, a member of the Committee for Ethics in Science at the Ministry of Science, head of the Bioethics Committee, Ministry of Health, and represents Poland in the Forum of National Ethics Committees to the European Commission. He has served as chair of the scientific committee for the workshop âThe Advancement of Science and the Dilemma of Dual Use,â held under the auspices of the Polish Academy of Sciences and UNESCO in November 2007. Indira Nath is Director of the Blue Peter Research Centre, Hyderabad, India. The center is part of the LEPRA Society, a leading Indian non- governmental organization working in the fields of leprosy, tuberculosis, malaria, HIV/AIDS, and disabilities. Dr. Nath previously served as dean of the School of Medicine at the Asian Institute of Medicine, Science and Technology in Malaysia. She was formerly S.N. Bose Research Professor, one of the five named national professorships endowed by the Indian National Science Academy in recognition of outstanding achievements in research. Dr. Nath also served as the founder head of the Depart- ment of Biotechnology at the All India Institute of Medical Sciences. After receiving her M.D., Dr. Nath worked as a house officer in hospitals in the United Kingdom and participated in a Nuffield Fellowship at Londonâs National Institute of Medical Research. Her area of specializa- tion is pathology with a special interest in the immunology of infectious diseases. Dr. Nath has received numerous awards including Padma Shri (1999), bestowed by the president of India for Individual Contribution in Immunology, Chevalier le National Order of Merite (2003), Docteur Honoris Causa (2003) awarded by the University Pierre and Marie Curie, LâOreal-UNESCO Women in Science (2002), the Shri Om Prakash Bhasin Foundation Award (1990), and the S.S. Bhatnagar Award of the Council for Scientific and Industrial Research (1983). She has served on several committees of the International Council for Science, including the Com- mittee on Science and Social Responsibility (2003) and the Scoping Group
82 APPENDIX A on Health (2006-2007). She has also served as a Country Representative to the UN Commission on Science and Technology for Development (2003- 2005), was a member of the Scientific Advisory Committee to the Cabinet (2003), a member of the Steering Committee in Science and Technology for 11th Planning Commission, Government of India (2006), and a member of the Working Group for Formulation of 11th Five Year Plan on Cross Disciplinary Technology Areas (2006). Dr. Nath is a fellow of the Indian National Science Academy, the Indian Academy of Sciences, the National Academy of Sciences (India), the National Academy of Medical Sciences (India), the Academy of Sciences for the Developing World (TWAS), and the Royal College of Pathologists, United Kingdom. Barbara Schaal (NAS) is the Spencer T. Olin Professor in Arts and Sci- ences in the Department of Biology at Washington University in St. Louis and vice president of the National Academy of Sciences. She is also chair of the NAS Council Committee on Scientific Programs and chair of the National Academies Division Committee for the Division of Earth and Life Studies. Dr. Schaal was elected to the National Academy of Sciences in 1999 for her investigations into the evolution of plant populations. Her work on the application of DNA analysis to plant evolution at the population level showed an unexpectedly high level of diversity due to limited gene migration. Her research includes the use of gene genealo- gies and coalescence theory to detect the geographical patterns of gene migration between populations of North American native plants. She also conducts studies on the species relationships in plants native to South America, Africa, and Asia and on issues related to the conservation of rare plants. Her current work examines gene flow and genetic diversity in wild and cultivated Asian rice. Dr. Schaal served as chairperson of Washington Universityâs Department of Biology (1993-1997), chairperson of the Scientific Advisory Council for the Center for Plant Conservation, president for the Society for the Study of Evolution, associate editor for the journal Molecular Biology and Evolution, and president of the Botanical Society of America. She received her Ph.D. in Population Biology from Yale University in 1974. Leiv Sydnes is professor of chemistry at the University of Bergen, Nor- way, a position he has held since 1993. His research is concentrated on organic synthesis with an emphasis on the application of cyclopropane chemistry and photochemistry to introduce useful structures into organic molecules. He received his Ph.D. in organic chemistry from the University of Oslo in 1978, conducted a postdoctoral fellowship at the University of Western Ontario, Canada, and previously served as an associate profes- sor and professor at the University of TromsÃ¸ (1980-1993). He has also
APPENDIX A 83 been a visiting professor at Iowa State University and a visiting fellow at the Australian National University, Canberra. Dr. Sydnes is past presi- dent of the International Union of Pure and Applied Chemistry (IUPAC) and chair of the IUPAC CHEMRAWN (CHEMical Research Applied to Word Needs) Committee. He has served on the organizing committee for two international workshops convened by IUPAC and the Organisation for the Prohibition of Chemical Weapons that have addressed trends in chemical sciences and technology ahead of the First and Second Chemi- cal Weapons Convention Review Conferences. He formerly served on the European Communities Chemistry Council, the European Communities Registration Board, and the Federation of European Chemical Societies, as well as serving as President of the Norwegian Chemical Society (1992- 1996). In addition to numerous articles in peer-reviewed scientific jour- nals, Dr. Sydnes has written more than 60 articles in national periodicals, including chemistry topics for nonspecialists and discussion papers on teaching. He has authored 5 books covering laboratory work in introduc- tory and intermediate organic chemistry at the university level, 19 high school chemistry textbooks, and 2 textbooks for chemical colleges, and has contributed chapters to numerous technical or more general scientific reports. Dr. Sydnes was elected to the Norwegian Academy of Science and Letters (1999) and his honors include Kyoto Institute of Technology Lectureship (1990), the Thaulow Prize (1995), and the Federation of the European Chemical Societies Medal (2003). He is also an elected fellow of the Royal Society of Chemistry (2004), an elected member of Academia Europaea (2005), and an elected fellow of the Federation of Asian Chemi- cal Societies (2005).